Reading time: 4 min
NovaBay Pharmaceuticals made eye drops. FDA-cleared wound care solution called NovaBay. Market cap: $30 million. On Monday the company announced it’s changing its name to Stablecoin Development Corporation, its ticker from NBY to SDEV, and its entire reason for existing. It holds 2.06 billion SKY tokens worth roughly $147 million. That’s nearly five times its own equity value. The ticker change goes live April 3.
An Eye Drop Company Now Owns 8.78% of a DeFi Protocol
Here’s what happened. In January 2026, NovaBay closed a $134 million private placement backed by Framework Ventures, Tether Investments, and Sky Frontier Foundation. With that money plus $70.7 million spent buying 1.09 billion SKY tokens on the open market at an average of $0.065 per token, the company built a position representing 8.78 percent of SKY’s total circulating supply. SKY is the governance token of the Sky protocol, the thing that used to be MakerDAO before it rebranded. Sky issues the USDS stablecoin and generates revenue through on-chain lending.
The company has already staked its holdings and earned 26.6 million SKY tokens in cumulative staking rewards as of March 16. The staking rate is currently above 10 percent annually according to the protocol’s published figures. CEO Michael Kazley called the company “the premier public market vehicle to access cash flows within the growing stablecoin economy.” Shares jumped 19 percent on Monday to about $1.40. They’re still down more than 95 percent year to date because the stock did a 1-for-5 reverse split in February as part of the restructuring.
The MicroStrategy Playbook Just Left Bitcoin
This is the Strategy (formerly MicroStrategy) playbook applied to DeFi governance tokens instead of Bitcoin. Strategy holds 762,099 BTC acquired for roughly $57.69 billion at an average of $75,694 per coin. That trade worked because Bitcoin had deep liquidity, institutional adoption via ETFs, and a supply cap that made accumulation a defensible thesis. SDEV is trying the same thing with a token that trades at $0.073 with a fraction of Bitcoin’s liquidity.
The concentration risk is the part that should make you pause. A $147 million position representing 8.78 percent of supply means any significant selling by SDEV would crater SKY’s price before the company could meaningfully exit. Warrants from the January placement carry a weighted-average exercise delay of roughly 9.9 months, and individual purchasers are capped at trading 10 percent of the 30-day average daily volume per day. That’s a lockup dressed up as a risk management parameter. If DeFi governance tokens enter another prolonged winter, SDEV shareholders don’t have a way out that doesn’t involve watching the token price collapse underneath them.
There’s also the governance angle that nobody’s talking about. When a single entity controls nearly 9 percent of a governance token’s supply, it doesn’t just earn yield. It accumulates voting power over the protocol’s collateral requirements, fee structures, and risk parameters. SDEV isn’t just a holder. It’s becoming a power broker inside the Sky ecosystem, and it’s doing it through a publicly traded shell that used to sell antimicrobial wound care products.
The Timing Is Not Random
Stablecoin legislation is moving in Washington. Lawmakers reached an agreement in principle last week on how stablecoin yield should be treated in a broader crypto market structure bill that’s heading to the Senate Banking Committee. The House Financial Services Committee convenes on March 25 to hold a hearing titled “Tokenization and the Future of Securities.” If the regulatory framework lands favourably for yield-bearing stablecoins, SDEV’s thesis looks prescient. If it doesn’t, the company is a $30 million shell sitting on $147 million of illiquid governance tokens with no pharmaceutical revenue to fall back on.
The bull case is straightforward: 10 percent staking yields dwarf anything NovaBay was generating selling eye drops. The stablecoin market is at roughly $230 billion and Standard Chartered projects it hitting $2 trillion by 2028. Tether backing the deal adds credibility. Framework Ventures backing the deal adds crypto-native legitimacy. And having a publicly traded stock ticker gives retail investors a way to get exposure to DeFi governance yields without setting up a wallet or staking directly.
The bear case is just as simple to spell out: a nanocap pharma company with a reverse-split stock and no operating business just bet everything on a single DeFi governance token during a war that’s repricing every risk asset on the planet. The 10 percent yield is denominated in a token that could go to zero. The 8.78 percent ownership stake means the exit door is exactly as wide as the market lets it be, which in a DeFi downturn is not very wide at all. SDEV trades on April 3.
For a complete timeline of how the Iran war reshaped global markets, see our reference page.
